Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 3 II, 2001, Pages

  Sigurs, Nele ^a  

^a BORÅS HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ALLERGY; ASTHMA; BRONCHIOLITIS; BRONCHUS OBSTRUCTION; BRONCHUS REACTIVITY; CHILD HOSPITALIZATION; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; FOLLOW UP; FORCED EXPIRATORY VOLUME; LOWER RESPIRATORY TRACT INFECTION; META ANALYSIS; MULTIVARIATE ANALYSIS; PEAK EXPIRATORY FLOW; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; SENSITIZATION; TREATMENT OUTCOME;

EID: 0035055865     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.supplement_1.2011109     Document Type: Conference Paper

References (37)

1. Respiratory syncytial virus infection: Diagnosis, treatment, and prevention
2. Serum antibodies against respiratory tract viruses: A prospective three-year follow-up from birth
3. Update: Respiratory syncytial virus activity - United States 1997-98 season
4. Respiratory syncytial virus
5. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life
6. Respiratory syncytial virus
7. Epidemiology of respiratory syncytial virus infection requiring hospitalization in east Denmark
8. Hospitalization for lower respiratory disease during 20 yrs among under 5 yr old children in Stockholm County: A population based survey
9. Bronchiolitis-associated hospitalizations among US children, 1980-1996
10. Pathogenesis and treatment of bronchiolitis
11. Bronchodilators for bronchiolitis (Cochrane Review)
12. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis
13. Anti-inflammatory therapy reduces wheezing after bronchiolitis
14. Sequelae of respiratory syncytial virus infection: A role for intervention studies
15. Asthma and wheezing in the first six years of life
16. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis
17. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy
18. Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing
19. Outcome of acute respiratory tract infection in infants: Preliminary report of seven-year follow-up study
20. Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy
21. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy
22. Bronchiolitis as a possible cause of wheezing in childhood: New evidence
23. Normal pulmonary function measurements and airway reactivity in childhood after mild bronchiolitis
24. Acute bronchiolitis: Predisposing factors and characterization of infants at risk
25. Respiratory status and allergy after bronchiolitis
26. Respiratory status and allergy nine to 10 years after acute bronchiolitis
27. Recurrent wheezing in children with respiratory syncytial virus (RSV) bronchiolitis in Qatar
28. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
29. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7
30. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
31. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: A quantitative review
32. Parental factors affecting respiratory function during the first year of life
33. Predictive value of respiratory syncytial virus - Specific IgE responses for recurrent wheezing following bronchiolitis
34. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years
35. Undetectable IgE responses after respiratory syncytial virus infection
36. Respiratory syncytial virus infection: Its role in aeroallergen sensitization during the first two years of life
37. Asthma related clinical and physiologic outcomes in high risk children 5-9 years after prophylaxis with RSV IgIV